Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy

Journal of Cardiac Failure

Volumn 10, Issue 2, 2004, Pages 132-140

  Stolen, Kira Q ^a   Kemppainen, Jukka ^a   Kalliokoski, Kari K ^a   Hällsten, Kirsti ^a   Luotolahti, Matti ^a   Karanko, Hannu ^b   Lehikoinen, Pertti ^a   Viljanen, Tapio ^a   Salo, Tiina ^a   Airaksinen, K E Juhani ^a   Nuutila, Pirjo ^a   Knuuti, Juhani ^a,c,d  

^a UNIVERSITY OF TURKU   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c TURKU PET CENTRE   (Finland)

^d NONE   (Finland)

Author keywords

functional capacity; Heart failure; positron emission tomography

Indexed keywords

CARBON 11; FLUORINE 18; GLUCOSE; INSULIN;

ADULT; AEROBIC METABOLISM; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE; FEMALE; GLUCOSE TRANSPORT; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE WORK; HEART MUSCLE PERFUSION; HEART RATE VARIABILITY; HEART RIGHT VENTRICLE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN CONSUMPTION; OXYGEN RADIOISOTOPES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; VENTRICULAR FUNCTION, LEFT; WATER;

EID: 3042758687     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.08.009     Document Type: Article

References (47)

1. Franciosa J.A., Park M., Levine T.B. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol. 47:1981;33-39
2. Higginbotham M.B., Morris K.G., Conn E.H., Coleman R.E., Cobb F.R. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol. 51:1983;52-60
3. Szlachcic J., Massie B.M., Kramer B.L., Topic N., Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 55:1985;1037-1042
4. Lapu-Bula R., Robert A., De Kock M., D'Hondt A.M., Detry J.M., Melin J.A., et al. Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 83:1999;728-734
5. Parthenakis F.I., Kanoupakis E.M., Kochiadakis G.E., Skalidis E.I., Mezilis N.E., Simantirakis E.N., et al. Left ventricular diastolic filling pattern predicts cardiopulmonary determinants of functional capacity in patients with congestive heart failure. Am Heart J. 140:2000;338-344
6. Ventura-Clapier R., De Sousa E., Veksler V. Metabolic myopathy in heart failure. News Physiol Sci. 17:2002;191-196
7. Katz S.D., Zheng H. Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure. J Nucl Cardiol. 9:2002;215-225
8. Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 27:1986;235-238
9. Pike V.W., Eakins M.N., Allan R.M., Selwyn A.P. Preparation of [1-11C]acetate - an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot. 33:1982;505-512
10. 2O production system for heart and brain studies. [abstract] J Labelled Cpd Radiopharm. 44:2001;S1066-S1068
11. Pitkanen O.P., Raitakari O.T., Niinikoski H., Nuutila P., Iida H., Voipio-Pulkki L.M., et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol. 28:1996;1705-1711
12. Nuutila P., Peltoniemi P., Oikonen V., Larmola K., Kemppainen J., Takala T., et al. Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes. 49:2000;1084-1091
13. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:1979;E214-E223
14. Alenius S., Ruotsalainen U. Bayesian image reconstruction for emission tomography based on median root prior. Eur J Nucl Med. 24:1997;258-265
15. Schelbert H., Schwaiger M. Positron emission tomography and autoradiography: principles and applications for the brain and heart. Phelps M., Marizziotta J., Schelbert H. PET studies of the heart. 1986;599-616 Raven Press, New York
16. Iida H., Takahashi A., Tamura Y., Ono Y., Lammertsma A.A. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med. 36:1995;78-85
17. Iida H., Rhodes C.G., de Silva R., Araujo L.I., Bloomfield P.M., Lammertsma A.A., et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med. 33:1992;1669-1677
18. Armbrecht J.J., Buxton D.B., Brunken R.C., Phelps M.E., Schelbert H.R. Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. Circulation. 80:1989;863-872
19. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlak C.S., Pettigrew K.D., et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 28:1977;897-916
20. Ng C.K., Soufer R., McNulty P.H. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake. J Nucl Med. 39:1998;379-383
21. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 55:1977;613-618
22. Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 56:1975;56-64
23. Hanson P. Exercise testing and training in patients with chronic heart failure. Med Sci Sports Exerc. 26:1994;527-537
24. Myers J., Froelicher V.F. Hemodynamic determinants of exercise capacity in chronic heart failure. Ann Intern Med. 115:1991;377-386
25. Meiler S.E., Ashton J.J., Moeschberger M.L., Unverferth D.V., Leier C.V. An analysis of the determinants of exercise performance in congestive heart failure. Am Heart J. 113:1987;1207-1217
26. Baker B.J., Wilen M.M., Boyd C.M., Dinh H., Franciosa J.A. Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. Am J Cardiol. 54:1984;596-599
27. Franciosa J.A., Baker B.J., Seth L. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J. 110:1985;807-813
28. Di Salvo T.G., Mathier M., Semigran M.J., Dec G.W. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 25:1995;1143-1153
29. Neglia D., Parodi O., Gallopin M., Sambuceti G., Giorgetti A., Pratali L., et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation. 92:1995;796-804
30. Neglia D., Michelassi C., Trivieri M.G., Sambuceti G., Giorgetti A., Pratali L., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 105:2002;186-193
31. Tamaki N., Magata Y., Takahashi N., Kawamoto M., Torizuka T., Yonekura Y., et al. Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion. Eur J Nucl Med. 20:1993;231-237
32. Armbrecht J.J., Buxton D.B., Schelbert H.R. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation. 81:1990;1594-1605
33. Brown M., Marshall D.R., Sobel B.E., Bergmann S.R. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation. 76:1987;687-696
34. Beanlands R.S., Armstrong W.F., Hicks R.J., Nicklas J., Moore C., Hutchins G.D., et al. The effects of afterload reduction on myocardial carbon 11-labeled acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy. J Nucl Cardiol. 1:1994;3-16
35. Beanlands R.S., Bach D.S., Raylman R., Armstrong W.F., Wilson V., Montieth M., et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol. 22:1993;1389-1398
36. Bengel F.M., Permanetter B., Ungerer M., Nekolla S., Schwaiger M. Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate - comparison between the normal and failing human heart. Eur J Nucl Med. 27:2000;319-326
37. Bottcher M., Refsgaard J., Gotzsche O., Andreasen F., Nielsen T.T. Effect of carvedilol on microcirculatory and glucose metabolic regulation in patients with congestive heart failure secondary to ischemic cardiomyopathy. Am J Cardiol. 89:2002;1388-1393
38. Beanlands R.S., Nahmias C., Gordon E., Coates G., deKemp R., Firnau G., et al. The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: a double-blind, placebo-controlled, positron-emission tomography study. Circulation. 102:2000;2070-2075
39. Ukkonen H., Saraste M., Akkila J., Knuuti J., Karanko M., Iida H., et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther. 68:2000;522-531
40. Takeyama D., Kagaya Y., Yamane Y., Shiba N., Chida M., Takahashi T., et al. Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat. Cardiovasc Res. 29:1995;763-767
41. Rosenblatt-Velin N., Montessuit C., Papageorgiou I., Terrand J., Lerch R. Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism. Cardiovasc Res. 52:2001;407-416
42. Davila-Roman V.G., Vedala G., Herrero P., de las F.L., Rogers J.G., Kelly D.P., et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 40:2002;271-277
43. Lommi J., Kupari M., Yki-Jarvinen H. Free fatty acid kinetics and oxidation in congestive heart failure. Am J Cardiol. 81:1998;45-50
44. Paolisso G., Gambardella A., Galzerano D., D'Amore A., Rubino P., Verza M., et al. Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism. 43:1994;174-179
45. Taylor M., Wallhaus T.R., DeGrado T.R., Russell D.C., Stanko P., Nickles R.J., et al. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in patients with congestive heart failure. J Nucl Med. 42:2001;55-62
46. van den Heuvel A.F., van Veldhuisen D.J., van der Wall E.E., Blanksma P.K., Siebelink H.M., Vaalburg W.M., et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 35:2000;19-28
47. Paternostro G., Camici P.G., Lammerstma A.A., Marinho N., Baliga R.R., Kooner J.S., et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest. 98:1996;2094-2099